These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 23559634)

  • 1. Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs.
    Wagner J; Riwanto M; Besler C; Knau A; Fichtlscherer S; Röxe T; Zeiher AM; Landmesser U; Dimmeler S
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1392-400. PubMed ID: 23559634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The influence of statin therapy on circulating microRNA-92a expression in patients with coronary heart disease].
    Wang H; Lu HM; Yang WH; Luo C; Lu SH; Zhou Y; Lin YZ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr; 24(4):215-8. PubMed ID: 22464573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcoronary concentration gradients of circulating microRNAs.
    De Rosa S; Fichtlscherer S; Lehmann R; Assmus B; Dimmeler S; Zeiher AM
    Circulation; 2011 Nov; 124(18):1936-44. PubMed ID: 21969012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal cutoff value of high-density lipoprotein cholesterol for predicting coronary artery disease in Taiwanese population.
    Huang YC; Ho CC; Lin PT; Lee BJ; Lai CH; Liaw YP
    Nutr Res; 2010 Jan; 30(1):21-6. PubMed ID: 20116656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise training improves high-density lipoprotein-mediated transcription of proangiogenic microRNA in endothelial cells.
    Riedel S; Radzanowski S; Bowen TS; Werner S; Erbs S; Schuler G; Adams V
    Eur J Prev Cardiol; 2015 Jul; 22(7):899-903. PubMed ID: 24958738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression.
    Tabuchi T; Satoh M; Itoh T; Nakamura M
    Clin Sci (Lond); 2012 Aug; 123(3):161-71. PubMed ID: 22364258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerotic Conditions Promote the Packaging of Functional MicroRNA-92a-3p Into Endothelial Microvesicles.
    Liu Y; Li Q; Hosen MR; Zietzer A; Flender A; Levermann P; Schmitz T; Frühwald D; Goody P; Nickenig G; Werner N; Jansen F
    Circ Res; 2019 Feb; 124(4):575-587. PubMed ID: 30582459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?
    Fichtlscherer S; Zeiher AM; Dimmeler S
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2383-90. PubMed ID: 22011751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcoronary gradients of HDL-associated MicroRNAs in unstable coronary artery disease.
    Choteau SA; Cuesta Torres LF; Barraclough JY; Elder AMM; Martínez GJ; Chen Fan WY; Shrestha S; Ong KL; Barter PJ; Celermajer DS; Rye KA; Patel S; Tabet F
    Int J Cardiol; 2018 Feb; 253():138-144. PubMed ID: 29306454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonoptimal high-density lipoprotein cholesterol levels are highly prevalent in patients presenting with acute coronary syndromes and well-controlled low-density lipoprotein cholesterol levels.
    Felix-Getzik EM; Kuvin JT; Karas RH
    J Clin Lipidol; 2010; 4(4):265-71. PubMed ID: 21122659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic value of high-density lipoproteins in the cardiology unit].
    Sampietro T; Bigazzi F; Dal Pino B; Landi P; Puntoni M; Minichilli F; Bianchi F; Chella E; Carpeggiani C; Bionda A
    Ital Heart J Suppl; 2004 Sep; 5(9):720-6. PubMed ID: 15568610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
    Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R
    Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines.
    Sachdeva A; Cannon CP; Deedwania PC; Labresh KA; Smith SC; Dai D; Hernandez A; Fonarow GC
    Am Heart J; 2009 Jan; 157(1):111-117.e2. PubMed ID: 19081406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic sensitivity of circulating cardio-enriched microRNAs is increased after normalization of high-density lipoprotein levels.
    Ram TP; Fomison-Nurse I; Gandhi S; Coffey S; Saxena P; Galvin I; Bunton R; Williams MJA; Lamberts RR; Katare R
    Int J Cardiol; 2017 Jun; 236():498-500. PubMed ID: 28169059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
    Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
    Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling.
    Riwanto M; Rohrer L; Roschitzki B; Besler C; Mocharla P; Mueller M; Perisa D; Heinrich K; Altwegg L; von Eckardstein A; Lüscher TF; Landmesser U
    Circulation; 2013 Feb; 127(8):891-904. PubMed ID: 23349247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease.
    Jansen F; Yang X; Proebsting S; Hoelscher M; Przybilla D; Baumann K; Schmitz T; Dolf A; Endl E; Franklin BS; Sinning JM; Vasa-Nicotera M; Nickenig G; Werner N
    J Am Heart Assoc; 2014 Oct; 3(6):e001249. PubMed ID: 25349183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.